The global bariatric surgical devices market, encompassing specialized equipment for weight loss procedures, is projected to reach a value of US$ 3.1 Bn by the year 2034. This represents a substantial growth from its valuation of US$ 1.5 Bn in 2023, driven by a CAGR of 6.6% between 2024 and 2034. Bariatric surgical devices, including trocars, stapling instruments, vessel sealing devices, suturing tools, adjustable gastric bands, gastric balloons, and electrical stimulators, play a crucial role in facilitating weight loss surgery by restricting stomach capacity and reducing nutrient absorption. These devices contribute to successful weight management outcomes by influencing the production of gut hormones that reduce appetite and enhance feelings of satiety.
Bariatric surgery, encompassing procedures like gastric bypass, gastric banding, and sleeve gastrectomy, offers a multifaceted solution for individuals battling obesity. These surgeries not only facilitate weight loss but also significantly improve metabolic health by regulating blood pressure, blood sugar, and cholesterol levels. Notably, bariatric surgery has proven to be an effective treatment option for class III obesity. The rising prevalence of lifestyle disorders such as diabetes and cardiovascular diseases (CVDs) is a major factor driving the growth of the bariatric surgical devices market. The increasing number of individuals struggling with weight-related problems, attributed to sedentary lifestyles and unhealthy dietary patterns, is further fueling the demand for these surgeries. For instance, the American Society for Metabolic and Bariatric Surgery estimates that nearly 280,000 metabolic and bariatric surgeries were performed in 2022, reflecting a 6.5% increase from the previous year.
Recent advancements in bariatric surgery have focused on enhancing patient outcomes, minimizing complications, and accelerating recovery times. Techniques such as endoscopic sleeve gastrectomy and mini gastric bypass have gained popularity due to their less invasive nature and shorter recovery periods. Moreover, robotic bariatric surgical devices have significantly improved precision and reduced the risk of complications during procedures. The industry has witnessed the introduction of several advanced devices in recent years, including the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx Systems by Apollo Endosurgery, Inc., and the Titan SGS stapling technology by Standard Bariatrics. These advancements are further contributing to the growth of the market.
North America holds the largest market value in 2023 and is expected to maintain its dominance throughout the forecast period. Several factors contribute to this regional dominance, including the high incidence of obesity and related health conditions, advancements in minimally invasive surgical techniques, growing awareness of the benefits of bariatric surgery, increased acceptance from both patients and healthcare providers, and robust government initiatives aimed at addressing obesity and its related health issues.
Key players in the bariatric surgical devices market include Agency for Medical Innovations, Apollo Endosurgery, Inc., Aspire Bariatrics, Cousin Biotech, EnteroMedics, Inc., Ethicon, Inc., Intuitive Surgical Inc., Mediflex Surgical Products, Medtronic PLC, and TransEnterix, Inc. These companies are actively involved in developing and introducing innovative devices that cater to the evolving needs of the market. In February 2024, BariaTek Medical, a France-based company, made significant progress with the first implantation of its BariTon device. This reversible implant offers a potential alternative to conventional weight loss surgery, promising a reduction in food intake and calorie absorption. The device is delivered endoscopically in an outpatient clinic and is expected to mimic the efficacy of sleeve gastrectomy and bypass surgery, two of the most common types of weight loss surgery.
The bariatric surgical devices market is segmented based on device type, end-user, and region. The device type segment is further categorized into assisting devices, such as suturing devices, stapling devices, closure devices, trocars, and others, and implantable devices, including gastric bands, gastric balloons, electrical stimulation devices, gastric emptying devices, and others. The end-user segment includes bariatric surgery clinics, ambulatory surgical centers, hospital pharmacies, and others. The regional market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Overall, the bariatric surgical devices market is poised for substantial growth in the coming years, driven by increasing obesity rates, advancements in surgical techniques, and a growing awareness of the benefits of bariatric surgery. As technology continues to evolve and patient demand for minimally invasive procedures grows, this market is expected to remain a significant player in the global healthcare landscape.
